Ethics of Gene Editing
By Betty Rollin,
KQED Religion & Ethics Newsweekly
| 07. 02. 2015
[with CGS's Marcy Darnovsky]
<span id="XinhaEditingPostion"></span>
A promising new medical technology has the potential to cure many genetic diseases by deleting or replacing defective genes. But ethicist Marcy Darnovsky of the Center for Genetics and Society is concerned about the safety of the technology, the unintended consequences of gene alteration for future generations, and the possibility of wealthy parents using the technology to “enhance” their children, regardless of medical necessity.
Image via WikiMedia Commons.
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Daniel Gilbert, The Washington Post | 03.07.2024
Vitaly Kushnir’s fertility clinic offers to screen an embryo to predict a baby’s sex, but the service can lead to ethically murky territory, like when a couple wanted it so their first child could be a boy.
But the couple...
By MANUEL ANSEDE, El País | 03.01.2024
A team of Italian researchers has reached a major scientific milestone, heralding a revolution in the field of medicine. The scientists have succeeded in silencing a gene associated with high cholesterol levels, without the need to modify DNA. In the...
By Anne Rumberger and Marcy Darnovsky, Science for the People | 02.29.2024
Eugenics is widely regarded as a debunked pseudoscience—developed and promoted mostly in Nazi Germany—that fell off the political radar after the horrors of the Holocaust were revealed. In fact, twentieth century eugenics represented the mainstream science of its day and...